Parity and lactation induce T-cell-mediated breast cancer protection
Balaji Virassamy(The University of Melbourne), Margaret C. Cummings(The University of Queensland), Michelle Cao, Liz Caldon(Garvan Institute of Medical Research), Kylie Clarke(Peter MacCallum Cancer Centre), Roberto Salgado(Institut Jules Bordet), Sneha Sant(Peter MacCallum Cancer Centre), Ashley Crook(Royal North Shore Hospital), Megan M. R. O’Malley(The University of Melbourne), Yoland Antill(Peninsula Health), Ian Campbell(The University of Sydney), Metta Jana(The University of Melbourne), Paul A. Cohen(The University of Western Australia), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Peter Savas(The University of Melbourne), Luis E. Lara Gonzalez(The University of Melbourne), Michael L. Hun(Australian Regenerative Medicine Institute), Han Xian Aw Yeang(University of Liverpool), Ian Bennett(Wesley Hospital), Jianan Wang(The University of Melbourne), Jo Burke(Royal Prince Alfred Hospital), Anannya Chakrabarti, Manisha Chauhan(Garvan Institute of Medical Research), Simon Bodek(University Hospitals Bristol NHS Foundation Trust), Eliza Courtney(Royal North Shore Hospital), Courtney T. van Geelen(The University of Melbourne), Rejhan Idrizi(The University of Melbourne), David J. Amor(The University of Melbourne), Emmaline Brown(Peter MacCallum Cancer Centre), Franco Caramia(The University of Melbourne), Phyllis Butow(Royal Prince Alfred Hospital), Rosemary L. Balleine(The University of Sydney), Thomas N. Burn(Children's Hospital of Philadelphia), Jonathan Beesley(The University of Melbourne), Jia Wern Pan(Cancer Research Malaysia), Alice Christian, Alison Colley(Liverpool Hospital), Jasmine Kay(The University of Melbourne), Michael F. Buckley(New South Wales Department of Health), Deepa Chauhan(The University of Sydney), James Cui(Monash University), Jamieson D Ballan(The University of Melbourne), Meagan Brennan(The University of Queensland), Damon J Challice(Peter MacCallum Cancer Centre), Michael A. Harris(The University of Melbourne)
Cited by 17
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Co-evolution of tumor cells and their microenvironment
|Trends in Genetics|2008|633